InMed Pharmaceuticals (INM) Revenue (2021 - 2025)
InMed Pharmaceuticals (INM) posted quarterly Revenue of $820188.0 for Q4 2025, down 26.22% year-over-year from $1.1 million in Q4 2024, and down 26.78% quarter-over-quarter from $1.1 million in Q3 2025.
InMed Pharmaceuticals (INM) Revenue (2021 - 2025) Analysis & Trends
InMed Pharmaceuticals' Revenue history runs 5 years deep, the most recent figure standing at $820188.0 for Q4 2025.
- In Q4 2025, Revenue fell 26.22% year-over-year to $820188.0; the TTM figure through Dec 2025 stood at $4.5 million (down 6.73% YoY), while the FY2025 annual figure was $4.9 million, up 7.5% from the prior year.
- Revenue for Q4 2025 stood at $820188.0, down from $1.1 million in the prior quarter.
- The five-year high for Revenue was $2.3 million in Q2 2023, with the low at $265092.0 in Q4 2021.
- The 5-year median for Revenue is $1.1 million (2024), against an average of $999769.6.
- The sharpest annual moves came in 2023 and 2024: Revenue surged 348.96% in 2023, then slumped 44.48% in 2024.
- InMed Pharmaceuticals' Revenue stood at $265092.0 in 2021, then jumped by 77.22% to $469783.0 in 2022, then soared by 163.99% to $1.2 million in 2023, then fell by 10.36% to $1.1 million in 2024, then dropped by 26.22% to $820188.0 in 2025.
- Business Quant data shows INM's Revenue at $820188.0 in Q4 2025, $1.1 million in Q3 2025, and $1.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | InMed Pharmaceuticals | 6.52 Mn | 1.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 820,188.00 |
| Sep 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 1.11 Mn |
| Sep 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | 1.24 Mn |
| Sep 30, 2023 | 901,862.00 |
| Jun 30, 2023 | 2.31 Mn |
| Mar 31, 2023 | 1.03 Mn |
| Dec 31, 2022 | 469,783.00 |
| Sep 30, 2022 | 320,788.00 |
| Jun 30, 2022 | 514,758.00 |
| Mar 31, 2022 | 600,000.00 |
| Dec 31, 2021 | 265,092.00 |